Treatment of Peritoneal Dissemination in Stomach Cancer Patients With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Rationale and Design of the PERISCOPE Study

BACKGROUND: Patients with gastric cancer and peritoneal carcinomatosis have a very poor prognosis; median survival is 3 to 4 months. Palliative systemic chemotherapy is currently the only treatment available in the Netherlands. Intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC) has an...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:JMIR Res Protoc
Auteurs principaux: van der Kaaij, Rosa T, Braam, Hidde JW, Boot, Henk, Los, Maartje, Cats, Annemieke, Grootscholten, Cecile, Schellens, Jan HM, Aalbers, Arend GJ, Huitema, Alwin DR, Knibbe, Catherijne AJ, Boerma, Djamila, Wiezer, Marinus J, van Ramshorst, Bert, van Sandick, Johanna W
Format: Artigo
Langue:Inglês
Publié: JMIR Publications 2017
Sujets:
Protocol
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5532515/
https://ncbi.nlm.nih.gov/pubmed/28705789
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2196/resprot.7790
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires